Who
Laurence N. Charney
Director
Company insider
Files Form 4 as: Director, TG Therapeutics; Director, Iconix Brand Group; Director, Marvel Entertainment.
In numbers
- Trades disclosed
- 46
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $2.5M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 10 Jul 2007
- Last trade
- 10 Sep 2026
- Last filed
- 14 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 14 Sep 2026 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $275K5,000 at $54.96 | filing |
| 10 Sep 2026filed 14 Sep 2026 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $275K5,000 at $54.96 | filing |
| 7 Aug 2026filed 7 Aug 2026 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —500 at $0.00 | filing |
| 7 Aug 2026filed 7 Aug 2026 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —450 at $0.00 | filing |
| 7 Aug 2026filed 7 Aug 2026 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —500 at $0.00 | filing |
| 7 Aug 2026filed 7 Aug 2026 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —450 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —5,100 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —5,100 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | TGTX TG Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,325 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | TGTX TG Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,325 at $0.00 | filing |
| 29 Jan 2026filed 29 Jan 2026 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —13,197 at $0.00 | filing |
| 29 Jan 2026filed 29 Jan 2026 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —13,197 at $0.00 | filing |
| 28 Jan 2026filed 29 Jan 2026 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —30,000 at $0.00 | filing |
| 28 Jan 2026filed 29 Jan 2026 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —30,000 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —21,408 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —6,000 at $0.00 | filing |
| 12 Nov 2024filed 12 Nov 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code G | —5,000 at $0.00 | filing |
| 11 Nov 2024filed 12 Nov 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $755K25,000 at $30.20 | filing |
| 19 Jun 2024filed 20 Jun 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —22,250 at $0.00 | filing |
| 12 Mar 2024filed 13 Mar 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $351K22,000 at $15.97 | filing |
News
No headline names them, or the companies they trade most, lately.